Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-08 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |